Company intelligence / Profile preview

Restoration Biologics

Flagstaff, Arizona, United Statesrestorationbiologics.com ↗

Ownership: Private
Employees: ~4
Development stage: Other

Overview

Restoration Biologics is in early-stage development applying cannabinoid-COX-2 conjugate compounds, and cannabinoid-steroid conjugates to address joint diseases such as osteoarthritis and rheumatoid arthritis. No clinical trial results have been reported as of 2025.

Therapeutic areas: ImmunologyRheumatology
Modalities: Small moleculeBiologic
Industry: Biotech

Partnerships

Enveric BiosciencesAkos Biosciences

Beyond the preview

Go deeper on Restoration Biologics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Restoration Biologics.